Kucukoglu, M. S. Et Al. 2021. Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study. ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.10 , 721-732.

Kucukoglu, M. S., HANTA, İ., AKDENİZ, B., Gullulu, S., Atahan, E., SAYIN, T., ... Okumus, G.(2021). Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study. ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.10, 721-732.

Kucukoglu, Mehmet Et Al. "Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study," ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.10, 721-732, 2021

Kucukoglu, Mehmet S. Et Al. "Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study." ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.10, pp.721-732, 2021

Kucukoglu, M. S. Et Al. (2021) . "Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study." ANATOLIAN JOURNAL OF CARDIOLOGY , vol.25, no.10, pp.721-732.

@article{article, author={Mehmet Serdar Kucukoglu Et Al. }, title={Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study}, journal={ANATOLIAN JOURNAL OF CARDIOLOGY}, year=2021, pages={721-732} }